B
BRVE
Braveheart Bio
Upcoming IPOs
Listing Date: --
OPEN/PREV CLOSE30.20/18.00
TODAY RANGE29.42-31.56
VOL498
MARKET CAP2.11B
52 WEEK RANGE29.42-31.56
AVG VOL (3M)3.29M
% TURNOVER4.66%
TURNOVER--
P/E (TTM)-1.7326
% RANGE11.91%
EPS(TTM)-17.2000
P/E(FORWARD)--
P/B--
BVPS--
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP558.75M
SHARES OUTSTANDING70.65M
NEXT EARNINGS--
FREE FLOAT18.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·18h ago
Heart drug developer Braveheart Bio surges on public debut after upsized IPO
TipRanks·19h ago
Braveheart Bio opens at $30.20, IPO priced at $18 per share
TipRanks·20h ago
Braveheart Bio indicated to open at $30, IPO priced at $18
TipRanks·1d ago
Braveheart Bio 21.25M share IPO priced at $18.00
Dow Jones·1d ago
Braveheart Bio Increases IPO Size With Pricing of $18 a Share
Dow Jones·1d ago
*Braveheart Bio Offering Expected to Close Aug. 7
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.